Global menu

Our global pages


Eversheds Sutherland advises H2 Equity Partners on its acquisition of Optegra International Limited (“Optegra”)

  • Czech Republic
  • Slovakia


    Eversheds Sutherland has advised H2 Equity Partners, a leading Western European investment firm, on its acquisition of Optegra, a pan-European eye care provider with operations in the UK, Poland and the Czech Republic.

    Optegra has dedicated eye hospitals and clinics across the UK and Poland. It operates under brand Lexum in the Czech Republic where it is one of the largest and most sought-after eye clinics.

    The Eversheds Sutherland Czech team was led by Marek Bomba, Principal Associate, with support from Associates Lucia Luptáková and Ondřej Beneš.

    Marek Bomba commented:

    We are delighted to have supported H2 Equity Partners, as well as our UK colleagues on the deal. Lexum is an outstanding brand and we wish Optegra and Lexum all the best with its continued growth plans.”


    This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.

    < Go back